[The role of thrombin activatable fibrinolysis inhibitors (TAFI) in coronary artery disease].
Lisowski
Piotr
P
Klinika Kardiochirurgii AM w Białymstoku. lispiotr@poczta.onet.pl
Małyszko
Jolanta
J
Jackowski
Ryszard
R
Myśliwiec
Michał
M
Lisowska
Anna
A
Łapiński
Tomasz
T
Pawlak
Krystyna
K
Hirnle
Tomasz
T
D000818:Animals; D025901:Carboxypeptidase B2 / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000473:pathology; D006801:Humans; D012307:Risk Factors
D025901:Carboxypeptidase B2